Related Experiment Video

Updated: Jul 8, 2026

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

Can matrix metalloproteinases be targeted in hepatic ischemia/reperfusion injury?

Andrew J Fowell, R Christopher Benyon

    Hepatology (Baltimore, Md.)
    |December 29, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
    09:22

    Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

    Published on: April 2, 2017

    Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
    07:05

    Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

    Published on: September 27, 2024

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
    05:59

    Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

    Published on: August 30, 2019

    Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
    09:22

    Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

    Published on: April 2, 2017

    Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
    07:05

    Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

    Published on: September 27, 2024

    Related Concept Videos

    Role of Matrix Metalloproteases in Degradation of ECM01:23

    Role of Matrix Metalloproteases in Degradation of ECM

    Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
    A...

    Articles linked to this work by shared authors, journal, and citation graph.

    Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosis.

    Frontline gastroenterology·2024

    Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans.

    Nature communications·2023

    Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver disease.

    Frontline gastroenterology·2021

    Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

    Gastroenterology·2020

    Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis.

    Hepatology (Baltimore, Md.)·2012

    Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.

    Biochemical and biophysical research communications·2011

    Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

    Hepatology (Baltimore, Md.)·2026

    Drug-Induced Liver Injury (DILI) in clinical trials: Views and practical updates from DILI specialists at FDA.

    Hepatology (Baltimore, Md.)·2026

    Genetic regulation of CPEB3-mediated alternative polyadenylation associated with survival of patients with hepatocellular carcinoma.

    Hepatology (Baltimore, Md.)·2026

    Beyond cirrhosis: Major adverse liver outcomes across homozygous and heterozygous Alpha-1 antitrypsin deficiency associated liver disease.

    Hepatology (Baltimore, Md.)·2026

    Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

    Hepatology (Baltimore, Md.)·2026

    A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

    Hepatology (Baltimore, Md.)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us